SC
CCCC icon

Steven Cohen’s C4 Therapeutics CCCC Stock Holding History

Steven Cohen’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$812K Buy
173,965
+4,869
+3% +$16.7K ﹤0.01% 2943
2026
Q1 		$445K Sell
169,096
-9,270,232
-98% -$21.8M ﹤0.01% 3166
2025
Q4 		$18M Buy
+9,439,328
New +$22.4M 0.02% 961
2025
Q2 		– Sell
-236,855
Closed -$379K – 2223
2025
Q1 		$379K Buy
236,855
+40,389
+21% +$120K ﹤0.01% 1699
2024
Q4 		$707K Sell
196,466
-1,005,382
-84% -$5M ﹤0.01% 1567
2024
Q3 		$6.85M Buy
1,201,848
+923,268
+331% +$5.56M 0.02% 782
2024
Q2 		$1.29M Sell
278,580
-627,892
-69% -$3.74M ﹤0.01% 1205
2024
Q1 		$7.41M Sell
906,472
-1,054,887
-54% -$8.18M 0.02% 836
2023
Q4 		$11.1M Buy
1,961,359
+1,945,338
+12,142% +$4.44M 0.03% 650
2023
Q3 		$29.8K Buy
16,021
+9,464
+144% +$28.9K ﹤0.01% 2231
2023
Q2 		$18K Sell
6,557
-17,176
-72% -$55.2K ﹤0.01% 1805
2023
Q1 		$74.5K Buy
+23,733
New +$140K ﹤0.01% 1693
2022
Q2 		– Sell
-503,888
Closed -$12.2M – 1421
2022
Q1 		$12.2M Buy
+503,888
New +$12.2M 0.05% 458
2021
Q4 		– Sell
-200,000
Closed -$8.94M – 1113
2021
Q3 		$8.94M Buy
200,000
+34,400
+21% +$1.47M 0.04% 519
2021
Q2 		$6.27M Buy
+165,600
New +$5.93M 0.03% 560

Other funds holding CCCC

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Steven Cohen's CCCC Position: Q2 2026 in Review

Steven Cohen increased its C4 Therapeutics (CCCC) stake by 2.9% in Q2 2026, buying an estimated $16.7K and bringing the position to 173,965 shares worth $812K. The position accounts for ﹤0.01% of the portfolio, ranked #2943.

Steven Cohen first reported a position in CCCC in Q2 2021 and has held it in 15 quarters since. The position peaked at $18M in Q4 2025. 147 funds tracked by Wall St. Rank hold CCCC as of Q2 2026.

  • Steven Cohen held 173,965 shares of C4 Therapeutics worth $812K as of Q2 2026.
  • Steven Cohen bought 4,869 C4 Therapeutics shares in Q2 2026, an estimated $16.7K.
  • C4 Therapeutics made up ﹤0.01% of Steven Cohen's portfolio in Q2 2026, its #2943 holding.
  • Steven Cohen first reported a position in C4 Therapeutics in Q2 2021 and has held it in 15 quarters since.
  • Steven Cohen's C4 Therapeutics position peaked at $18M in Q4 2025.
  • 147 funds tracked by Wall St. Rank held C4 Therapeutics as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.